Search
Results: 8
Innate Immune Mechanisms to Protect Against Infection at the Human Decidual-Placental Interface.
During pregnancy, the placenta forms the anatomical barrier between the mother and developing fetus. Infectious agents can potentially breach the placental barrier resulting in pathogenic transmission from mother to fetus....
Generation COVID-19 - Should the foetus be worried?
Aysha Iqbal, Charlotte Burrin, Ezra Aydin, Kathryn Beardsall, Hilary Wong, Topun Austin
Dec 11, 2020
AIM: The aim of this narrative review was to evaluate the risks, both direct and indirect, to the foetus from the COVID-19 pandemic. METHODS: Direct and indirect risks were defined as (a) vertical infection (congenital or...
Ebola
Jonathan L Heeney
Dec 03, 2015
Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance.
Antonia Hufnagel, Denise S Fernandez-Twinn, Heather L Blackmore, Thomas J Ashmore, Robert A Heaton, Benjamin Jenkins, Albert Koulman, Iain P Hargreaves, Catherine E Aiken, Susan E Ozanne
Oct 01, 2021
Maternal obesity is a global problem that increases the risk of short- and long-term adverse outcomes for mother and child, many of which are linked to gestational diabetes mellitus. Effective treatments are essential to prevent...
Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria.
Nicaise Ndembi, Fati Murtala-Ibrahim, Monday Tola, Jibreel Jumare, Ahmad Aliyu, Peter Alabi, Charles Mensah, Alash'le Abimiku, Miguel E Quiñones-Mateu, Trevor A Crowell, Soo-Yon Rhee, Robert W Shafer, Ravindra Gupta, William Blattner, Manhattan E Charurat, Patrick Dakum
Nov 30, 2020
BACKGROUND: A substantial number of persons living with HIV (PLWH) in Nigeria do not experience durable viral suppression on first-line antiretroviral therapy (ART). Understanding risk factors for first-line treatment failure...
A role for BCL2L13 and autophagy in germline purifying selection of mtDNA.
Laura S Kremer, Lyuba V Bozhilova, Diana Rubalcava-Gracia, Roberta Filograna, Mamta Upadhyay, Camilla Koolmeister, Patrick F Chinnery, Nils-Göran Larsson
Jan 19, 2023
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa
Andrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, Diane Havlir, Anton Pozniak, Daniel R Kuritzkes, Annemarie Wensing, Jens D Lundgren, Deenan Pillay, John Mellors, Valentina Cambiano, Andreas Jahn, Tsitsi Apollo, Owen Mugurungi, David Ripin, Juliana Da Silva, Elliot Raizes, Nathan Ford, George K Siberry, Ravindra K Gupta, Ruanne Barnabas, Paul Revill, Jennifer Cohn, Alexandra Calmy, Silvia Bertagnolio
Mar 16, 2020
BACKGROUND: The integrase inhibitor dolutegravir is being considered in several countries in sub-Saharan Africa instead of efavirenz for people initiating antiretroviral therapy (ART) because of superior tolerability and a lower...
Adolescent Adult Africa South of the Sahara Alkynes Anti-HIV Agents Benzoxazines Cost-Benefit Analysis Cyclopropanes Female HIV Infections Heterocyclic Compounds 3-Ring Humans Infectious Disease Transmission Vertical Male Middle Aged Oxazines Piperazines Practice Guidelines as Topic Pregnancy Pregnancy Complications Pyridones Randomized Controlled Trials as Topic Young Adult
Vertical transmission of Anaplasma platys and Leishmania infantum in dogs during the first half of gestation.
Maria Stefania Latrofa, Filipe Dantas-Torres, Donato de Caprariis, Cinzia Cantacessi, Gioia Capelli, Riccardo Paolo Lia, Edward B Breitschwerdt, Domenico Otranto
May 09, 2016